Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis. Nishihara H, Shimizu F, Kitagawa T, Yamanaka N, Akada J, Kuramitsu Y, Sano Y, Takeshita Y, Maeda T, Abe M, et al. Mult Scler. 2016 Jun 23. PMID: 27339072. Abstract CommentRecommendBookmarkWatch